MPLT R&D Expenses
Maplight Therapeutics Inc · R&D Expenses
MPLT R&D Expenses
Latest reported$53.44Mperiod ending
MPLT Quarterly R&D Expenses ($10.42M → $53.44M)
Quarterly R&D Expenses
High-resolution chart · PNG
MPLT r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 53,435,000 | |
| 53,684,000 | |
| 64,483,000 | |
| 27,094,000 | |
| 26,711,000 | |
| 19,620,000 | |
| 20,713,000 | |
| 16,814,000 | |
| 15,469,000 | |
| 15,200,000 | |
| 10,420,000 |